# Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

> **NCT02985333** · PHASE2 · WITHDRAWN · sponsor: **Sun Yat-sen University**

## Conditions studied

- Relapse/Refractory Multiple Myeloma

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Cyclophosphamide
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT02985333
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-06
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2018-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985333, "Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02985333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*